- Home
- CDRE vs IMTX Comparison
CDRE vs IMTX Comparison
Compare CDRE & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDRE | IMTX |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | Germany |
| Employees | N/A | 407 |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CDRE | IMTX |
|---|---|---|
| Price | $30.39 | $11.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $39.67 | $19.00 |
| AVG Volume (30 Days) | 419.9K | ★ 454.9K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.46% | N/A |
| EPS Growth | ★ 13.33 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $610,308,000.00 | N/A |
| Revenue This Year | $23.72 | N/A |
| Revenue Next Year | $6.89 | $25.91 |
| P/E Ratio | $597.73 | ★ N/A |
| Revenue Growth | ★ 7.53 | N/A |
| 52 Week Low | $25.73 | $4.93 |
| 52 Week High | $48.76 | $12.41 |
Technical Indicators
Market Signals| Indicator | CDRE | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.97 | 59.70 |
| Support Level | $29.19 | $9.24 |
| Resistance Level | $31.56 | $12.00 |
| Average True Range (ATR) | 1.65 | 0.61 |
| MACD | 0.17 | -0.01 |
| Stochastic Oscillator | 78.80 | 89.20 |
Price Performance
Historical ComparisonAbout CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.